The Real-World Observational Prospective Study of Health Outcomes with Dulaglutide and Liraglutide in Type 2 Diabetes Patients (TROPHIES): Design and Baseline Characteristics

INTRODUCTION: The TROPHIES observational study enrolled patients with type 2 diabetes mellitus (T2DM) initiating their first injectable treatment with the glucagon-like peptide 1 receptor agonists (GLP-1 RAs) dulaglutide or liraglutide. This manuscript focuses on the study design, baseline character...

Descripción completa

Detalles Bibliográficos
Autores principales: García-Pérez, Luis-Emilio, Boye, Kristina S., Rosilio, Myriam, Jung, Heike, Heitmann, Elke, Norrbacka, Kirsi, Federici, Marco Orsini, Gentilella, Raffaella, Guerci, Bruno, Giorgino, Francesco, Aigner, Ulrich, Sapin, Hélène
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8266969/
https://www.ncbi.nlm.nih.gov/pubmed/34097244
http://dx.doi.org/10.1007/s13300-021-01076-0

Ejemplares similares

Ejemplares similares